Diabetes, hypertension and erythrocyte aggregation in acute stroke

Nancy Beamer, George Giraud, Wayne Clark, Mike Wynn, Bruce M Coull

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Elevated erythrocyte (RBC) aggregation (RBC-A) may contribute to the pathogenesis of stroke and stroke recurrence. We measured RBC-A at low shear in 55 patients with acute ischemic stroke and in 24 age-balanced controls without cerebrovascular disease or vascular risk factors. RBC-A was significantly elevated in subgroups of stroke patients who were hypertensive, diabetic, or both, compared with either stroke patients lacking these risk factors (p at least < 0.01) or healthy elderly (all p < 0.001). RBC-A was normal in stroke patients (n = 14) free of both diabetes and hypertension. In a multivariate linear regression model glycosylated hemoglobin (p < 0.0001), plasma viscosity (p < 0.006) and systolic blood pressure (p < 0.05) were each independently significant and together accounted for about 52% of the variation in RBC-A in acute stroke patients. No relationship was detected between RBC-A and infarct size or among the major subtypes of ischemic stroke. The results suggest that vigorous control of both blood glucose and blood pressure may reduce the potentially damaging effects of elevated RBC-A in the cerebral vasculature.

Original languageEnglish (US)
Pages (from-to)144-149
Number of pages6
JournalCerebrovascular Diseases
Volume7
Issue number3
StatePublished - May 1997
Externally publishedYes

Fingerprint

Erythrocyte Aggregation
Stroke
Hypertension
Blood Pressure
Linear Models
Cerebrovascular Disorders
Glycosylated Hemoglobin A
Viscosity
Blood Glucose
Recurrence

Keywords

  • Diabetes
  • Erythrocyte aggregation
  • Fibrinogen
  • Glycosylated hemoglobin
  • Hypertension
  • Hyperviscosity
  • Ischemic stroke
  • Stroke mechanism

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Beamer, N., Giraud, G., Clark, W., Wynn, M., & Coull, B. M. (1997). Diabetes, hypertension and erythrocyte aggregation in acute stroke. Cerebrovascular Diseases, 7(3), 144-149.

Diabetes, hypertension and erythrocyte aggregation in acute stroke. / Beamer, Nancy; Giraud, George; Clark, Wayne; Wynn, Mike; Coull, Bruce M.

In: Cerebrovascular Diseases, Vol. 7, No. 3, 05.1997, p. 144-149.

Research output: Contribution to journalArticle

Beamer, N, Giraud, G, Clark, W, Wynn, M & Coull, BM 1997, 'Diabetes, hypertension and erythrocyte aggregation in acute stroke', Cerebrovascular Diseases, vol. 7, no. 3, pp. 144-149.
Beamer, Nancy ; Giraud, George ; Clark, Wayne ; Wynn, Mike ; Coull, Bruce M. / Diabetes, hypertension and erythrocyte aggregation in acute stroke. In: Cerebrovascular Diseases. 1997 ; Vol. 7, No. 3. pp. 144-149.
@article{9b4893e8ac134881b2ae7cc8f51495fe,
title = "Diabetes, hypertension and erythrocyte aggregation in acute stroke",
abstract = "Elevated erythrocyte (RBC) aggregation (RBC-A) may contribute to the pathogenesis of stroke and stroke recurrence. We measured RBC-A at low shear in 55 patients with acute ischemic stroke and in 24 age-balanced controls without cerebrovascular disease or vascular risk factors. RBC-A was significantly elevated in subgroups of stroke patients who were hypertensive, diabetic, or both, compared with either stroke patients lacking these risk factors (p at least < 0.01) or healthy elderly (all p < 0.001). RBC-A was normal in stroke patients (n = 14) free of both diabetes and hypertension. In a multivariate linear regression model glycosylated hemoglobin (p < 0.0001), plasma viscosity (p < 0.006) and systolic blood pressure (p < 0.05) were each independently significant and together accounted for about 52{\%} of the variation in RBC-A in acute stroke patients. No relationship was detected between RBC-A and infarct size or among the major subtypes of ischemic stroke. The results suggest that vigorous control of both blood glucose and blood pressure may reduce the potentially damaging effects of elevated RBC-A in the cerebral vasculature.",
keywords = "Diabetes, Erythrocyte aggregation, Fibrinogen, Glycosylated hemoglobin, Hypertension, Hyperviscosity, Ischemic stroke, Stroke mechanism",
author = "Nancy Beamer and George Giraud and Wayne Clark and Mike Wynn and Coull, {Bruce M}",
year = "1997",
month = "5",
language = "English (US)",
volume = "7",
pages = "144--149",
journal = "Cerebrovascular Diseases",
issn = "1015-9770",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Diabetes, hypertension and erythrocyte aggregation in acute stroke

AU - Beamer, Nancy

AU - Giraud, George

AU - Clark, Wayne

AU - Wynn, Mike

AU - Coull, Bruce M

PY - 1997/5

Y1 - 1997/5

N2 - Elevated erythrocyte (RBC) aggregation (RBC-A) may contribute to the pathogenesis of stroke and stroke recurrence. We measured RBC-A at low shear in 55 patients with acute ischemic stroke and in 24 age-balanced controls without cerebrovascular disease or vascular risk factors. RBC-A was significantly elevated in subgroups of stroke patients who were hypertensive, diabetic, or both, compared with either stroke patients lacking these risk factors (p at least < 0.01) or healthy elderly (all p < 0.001). RBC-A was normal in stroke patients (n = 14) free of both diabetes and hypertension. In a multivariate linear regression model glycosylated hemoglobin (p < 0.0001), plasma viscosity (p < 0.006) and systolic blood pressure (p < 0.05) were each independently significant and together accounted for about 52% of the variation in RBC-A in acute stroke patients. No relationship was detected between RBC-A and infarct size or among the major subtypes of ischemic stroke. The results suggest that vigorous control of both blood glucose and blood pressure may reduce the potentially damaging effects of elevated RBC-A in the cerebral vasculature.

AB - Elevated erythrocyte (RBC) aggregation (RBC-A) may contribute to the pathogenesis of stroke and stroke recurrence. We measured RBC-A at low shear in 55 patients with acute ischemic stroke and in 24 age-balanced controls without cerebrovascular disease or vascular risk factors. RBC-A was significantly elevated in subgroups of stroke patients who were hypertensive, diabetic, or both, compared with either stroke patients lacking these risk factors (p at least < 0.01) or healthy elderly (all p < 0.001). RBC-A was normal in stroke patients (n = 14) free of both diabetes and hypertension. In a multivariate linear regression model glycosylated hemoglobin (p < 0.0001), plasma viscosity (p < 0.006) and systolic blood pressure (p < 0.05) were each independently significant and together accounted for about 52% of the variation in RBC-A in acute stroke patients. No relationship was detected between RBC-A and infarct size or among the major subtypes of ischemic stroke. The results suggest that vigorous control of both blood glucose and blood pressure may reduce the potentially damaging effects of elevated RBC-A in the cerebral vasculature.

KW - Diabetes

KW - Erythrocyte aggregation

KW - Fibrinogen

KW - Glycosylated hemoglobin

KW - Hypertension

KW - Hyperviscosity

KW - Ischemic stroke

KW - Stroke mechanism

UR - http://www.scopus.com/inward/record.url?scp=0030902645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030902645&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 144

EP - 149

JO - Cerebrovascular Diseases

JF - Cerebrovascular Diseases

SN - 1015-9770

IS - 3

ER -